BioCentury
ARTICLE | Clinical News

CaCP29: Phase II started

June 13, 2016 7:00 AM UTC

InflaRx began the double-blind, placebo-controlled, German Phase II CARDIAC trial to evaluate IFX-1 in 100 patients undergoing complex cardiac surgery. The surgery is defined as invasive open heart an...